Global Genome Engineering Editing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Genome Engineering Editing market size was valued at US$ 7276 million in 2024 and is forecast to a readjusted size of USD 23280 million by 2031 with a CAGR of 18.0% during review period.

Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.

Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.

This report is a detailed and comprehensive analysis for global Genome Engineering Editing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Genome Engineering Editing market size and forecasts, in consumption value ($ Million), 2020-2031

Global Genome Engineering Editing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Genome Engineering Editing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Genome Engineering Editing market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Genome Engineering Editing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon（Horizo​​n Discovery）, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Genome Engineering Editing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
CRISPR RNP
CRISPR mRNA
CRISPR Virus Delivery
Others

Market segment by Application
RUO
GMP

Market segment by players, this report covers
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon（Horizo​​n Discovery）
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
Illumina
Editas Medicine
Agilent Technologies
QIAGEN NV

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Genome Engineering Editing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Genome Engineering Editing, with revenue, gross margin, and global market share of Genome Engineering Editing from 2020 to 2025.

Chapter 3, the Genome Engineering Editing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Genome Engineering Editing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Genome Engineering Editing.

Chapter 13, to describe Genome Engineering Editing research findings and conclusion.